DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo


company name or ticker

Why Tesaro (TSRO) Stock Is Surging Today

Don't Get Excited About the Jump in Small Caps

Benzinga's Volume Movers

Monday’s Top Health Care Stories: Tesaro, Alnylam, Allergan, and Valeant

Tesaro, Alnylam, Allergan, and Valeant could make waves across the health-care sector this morning.

Benzinga's Top #PreMarket Gainers

TESARO's CEO Presents at Deutsche Bank 39th Annual Health Care Conference - Transcript

Biotech of the Week: Opko Health Inc.

Opko Health competes with Laboratory Corporation of America and Quest Diagnostics on the diagnostics side and is partnered with Tesaro on the therapeutics side.

Relative Strength Alert For Tesaro

Should You Buy Tesaro After Its Earnings Miss?

Tesaro just missed earnings estimates by $0.37 per share for its first quarter. Is this stock a bad news buy?

TESARO's (TSRO) CEO Lonnie Moulder on Q1 2014 Earnings - Call Transcript

See More Articles...